MenQuadfi™ Meningococcal (Groups A, C, Y, and W-135) Conjugate Vaccine, SDV, Preservative Free, 10 mcg/0.5 ml Injection, Carton/10 Vials

Product Overview

MenQuadfi™ Meningococcal (Groups A, C, Y, and W-135) Conjugate Vaccine is a highly effective vaccine designed to provide protection against four major serogroups of Neisseria meningitidis: A, C, Y, and W-135. It is a conjugate vaccine, meaning it links the polysaccharide antigen from each serogroup to a protein carrier, which enhances the immune response. This preservative-free, single-dose vial formulation is available in a 10 mcg/0.5 ml injection, and is provided in a carton containing 10 vials, making it an ideal choice for healthcare providers to ensure optimal meningococcal protection. This vaccine is indicated for use in individuals who are at risk for meningococcal disease, particularly in populations with a higher risk such as adolescents, travelers, and individuals with certain medical conditions.

Product Features 

• Provides protection against four major meningococcal serogroups (A, C, Y, and W-135), which are the most common causes of invasive meningococcal disease worldwide.
• Free from preservatives, making it suitable for individuals who may have sensitivities to these ingredients.
• Each vial contains a 0.5 ml dose (10 mcg) of the vaccine, ensuring easy administration and reducing the risk of wastage.
• Enhances the immune response, especially in individuals who may not respond as effectively to polysaccharide vaccines, such as infants and young children.
• Supplied in a convenient carton containing 10 vials, ideal for medical practices, clinics, and healthcare settings that need to immunize multiple individuals.

Product Specifications